Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
arborpharma.com

See what CB Insights has to offer

Business Relationships

3

Service Providers

1

Arbor Pharmaceuticals Service Providers

1 Service Provider

Arbor Pharmaceuticals has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Private Equity

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Private Equity

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Arbor Pharmaceuticals Partners & Customers

3 Partners and customers

Arbor Pharmaceuticals has 3 strategic partners and customers. Arbor Pharmaceuticals recently partnered with Debiopharm Group on January 1, 2016.

Date

Type

Business Partner

Country

News Snippet

Sources

1/11/2016

Licensor

Debiopharm Group

Switzerland

Debiopharm International SA and Arbor Pharmaceuticals, LLC announce their US commercialization partnership for Triptorelin in Central Precocious Puberty - Debiopharm, We develop for patients

Lausanne , Switzerland and Atlanta , GA USA -- January 11 , 2016 -- Debiopharm International SA , part of Debiopharm Group ™ , a Swiss-based global biopharmaceutical company , and Arbor Pharmaceuticals , LLC , LCC , a U.S.-based specialty pharmaceutical company , jointly announce the execution of a distribution agreement for the commercialization and promotion of triptorelin 22.5 mg in the United States for central precocious puberty .

1

9/12/2013

Licensor

Takeda Pharmaceutical

Japan

Subscribe to see more

Subscribe to see more

10

Licensee

Eisai

Japan

Subscribe to see more

Subscribe to see more

10

Date

1/11/2016

9/12/2013

Type

Licensor

Licensor

Licensee

Business Partner

Debiopharm Group

Takeda Pharmaceutical

Eisai

Country

Switzerland

Japan

Japan

News Snippet

Debiopharm International SA and Arbor Pharmaceuticals, LLC announce their US commercialization partnership for Triptorelin in Central Precocious Puberty - Debiopharm, We develop for patients

Lausanne , Switzerland and Atlanta , GA USA -- January 11 , 2016 -- Debiopharm International SA , part of Debiopharm Group ™ , a Swiss-based global biopharmaceutical company , and Arbor Pharmaceuticals , LLC , LCC , a U.S.-based specialty pharmaceutical company , jointly announce the execution of a distribution agreement for the commercialization and promotion of triptorelin 22.5 mg in the United States for central precocious puberty .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.